SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD./ADR
Clinical trial NCT07329322 updates: 1. enrollment: 60 → 30 participants 2. allocation: RANDOMIZED → NA 3. intervention model: PARALLEL → SINGLE_GROUP
Clinical trial NCT07329322 updates: 1. enrollment: 60 → 30 participants 2. allocation: RANDOMIZED → NA 3. intervention model: PARALLEL → SINGLE_GROUP
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical